Goldfinch Bio IPO

goldfinchbio.com

Goldfinch Bio leverages a genomics-based, precision medicine approach to discovering and developing kidney disease treatments.

Founded2015
Total Funding to Date$190.22MM
Register for Details

For more details on financing and valuation for Goldfinch Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Goldfinch Bio Ticker Symbol

Goldfinch Bio does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Goldfinch Bio Stock Price

The stock price for Goldfinch Bio will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Goldfinch Bio Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
6/30/2020 Series B $252.06MM $XXX.XX $XXX.XX
5/8/2019 Series A $112.42MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Goldfinch Bio in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B